Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
Upcoming Events
TD Cowen Immunology & Inflammation Summit
Past Events
American College of Rheumatology (ACR) Convergence 2025
Chicago, IL
Morgan Stanley 23rd Annual Global Healthcare Conference
2025 Wells Fargo Healthcare Conference
European Alliance of Associations for Rheumatology (EULAR) 2025 Congress
Barcelona, Spain